share_log

Rumere's (SZSE:301088) Problems Go Beyond Weak Profit

Rumere's (SZSE:301088) Problems Go Beyond Weak Profit

魯梅爾(SZSE:301088)的問題不僅僅是利潤疲軟
Simply Wall St ·  2022/04/29 18:51

The subdued market reaction suggests that Rumere Co., Ltd.'s (SZSE:301088) recent earnings didn't contain any surprises. We think that investors are worried about some weaknesses underlying the earnings.

低迷的市場反應表明魯梅爾股份有限公司的(SZSE:301088)近期財報並不包含任何意外。我們認為,投資者擔心的是盈利背後的一些弱點。

See our latest analysis for Rumere

查看我們對Rumere的最新分析

SZSE:301088 Earnings and Revenue History April 29th 2022
SZSE:301088收益和收入歷史2022年4月29日

A Closer Look At Rumere's Earnings

仔細看看魯梅爾的收入

In high finance, the key ratio used to measure how well a company converts reported profits into free cash flow (FCF) is the accrual ratio (from cashflow). To get the accrual ratio we first subtract FCF from profit for a period, and then divide that number by the average operating assets for the period. The ratio shows us how much a company's profit exceeds its FCF.

在高端金融領域,衡量一家公司將報告利潤轉換為自由現金流(FCF)的程度的關鍵比率是應計比率(來自現金流)。為了得到應計比率,我們首先從一個時期的利潤中減去FCF,然後用這個數字除以該時期的平均運營資產。這個比率向我們展示了一家公司的利潤超過了它的FCF的多少。

As a result, a negative accrual ratio is a positive for the company, and a positive accrual ratio is a negative. While having an accrual ratio above zero is of little concern, we do think it's worth noting when a company has a relatively high accrual ratio. That's because some academic studies have suggested that high accruals ratios tend to lead to lower profit or less profit growth.

因此,負的應計比率對公司是積極的,而正的應計比率是負的。雖然應計比率高於零並不令人擔憂,但我們確實認為,當一家公司的應計比率相對較高時,這一點值得注意。這是因為一些學術研究表明,高應計制比率往往會導致較低的利潤或較低的利潤增長。

Rumere has an accrual ratio of 0.35 for the year to March 2022. Therefore, we know that it's free cashflow was significantly lower than its statutory profit, raising questions about how useful that profit figure really is. Over the last year it actually had negative free cash flow of CN¥61m, in contrast to the aforementioned profit of CN¥157.7m. We saw that FCF was CN¥97m a year ago though, so Rumere has at least been able to generate positive FCF in the past. However, that's not all there is to consider. The accrual ratio is reflecting the impact of unusual items on statutory profit, at least in part.

Rumere在截至2022年3月的一年中的應計比率為0.35。因此,我們知道它的自由現金流明顯低於其法定利潤,這引發了人們對這個利潤數字到底有多大用處的疑問。在過去的一年裏,它實際上負面自由現金流為人民幣6100萬元,而前述利潤為人民幣1.577億元。我們看到一年前的FCF是9700萬加元,所以Rumere至少在過去能夠產生正的FCF。然而,這並不是需要考慮的全部問題。應計比率反映了不尋常項目對法定利潤的影響,至少在一定程度上是這樣。

That might leave you wondering what analysts are forecasting in terms of future profitability. Luckily, you can click here to see an interactive graph depicting future profitability, based on their estimates.

這可能會讓你想知道,分析師對未來盈利能力的預測是什麼。幸運的是,您可以單擊此處查看基於他們估計的未來盈利能力的互動圖表。

The Impact Of Unusual Items On Profit

異常項目對利潤的影響

Given the accrual ratio, it's not overly surprising that Rumere's profit was boosted by unusual items worth CN¥14m in the last twelve months. While we like to see profit increases, we tend to be a little more cautious when unusual items have made a big contribution. When we crunched the numbers on thousands of publicly listed companies, we found that a boost from unusual items in a given year is often not repeated the next year. Which is hardly surprising, given the name. Assuming those unusual items don't show up again in the current year, we'd thus expect profit to be weaker next year (in the absence of business growth, that is).

考慮到應計比率,魯梅爾的利潤在過去12個月裏被價值1400萬元人民幣的不尋常項目提振也就不足為奇了。雖然我們喜歡看到利潤增加,但當不尋常的項目做出了很大貢獻時,我們往往會更加謹慎。當我們分析了數千家上市公司的數據時,我們發現,在給定的一年中,不尋常的項目往往會帶來提振第二年又重複了一遍。考慮到這個名字,這並不令人驚訝。假設這些不同尋常的項目在本年度不會再次出現,我們因此預計明年的利潤會更弱(也就是説,在沒有業務增長的情況下)。

Our Take On Rumere's Profit Performance

我們對Rumere的利潤表現的看法

Rumere had a weak accrual ratio, but its profit did receive a boost from unusual items. Considering all this we'd argue Rumere's profits probably give an overly generous impression of its sustainable level of profitability. In light of this, if you'd like to do more analysis on the company, it's vital to be informed of the risks involved. Be aware that Rumere is showing 3 warning signs in our investment analysis and 1 of those shouldn't be ignored...

Rumere的應計比率較低,但其利潤確實得到了不尋常項目的提振。考慮到這一切,我們認為Rumere的利潤可能給人一種過於慷慨的印象,表明其可持續的盈利水平。有鑑於此,如果你想對公司做更多的分析,瞭解其中的風險是至關重要的。請注意,Rumere在我們的投資分析中顯示了3個警告信號,其中1個不應被忽視…

Our examination of Rumere has focussed on certain factors that can make its earnings look better than they are. And, on that basis, we are somewhat skeptical. But there is always more to discover if you are capable of focussing your mind on minutiae. For example, many people consider a high return on equity as an indication of favorable business economics, while others like to 'follow the money' and search out stocks that insiders are buying. So you may wish to see this free collection of companies boasting high return on equity, or this list of stocks that insiders are buying.

我們對Rumere的調查集中在某些因素上,這些因素可以讓Rumere的收益看起來比實際情況更好。在此基礎上,我們對此持懷疑態度。但如果你有能力將注意力集中在細枝末節上,總會有更多的東西需要發現。例如,許多人認為高股本回報率是有利的商業經濟指標,而另一些人則喜歡“跟着錢走”,尋找內部人士正在買入的股票。所以你可能想看看這個免費擁有高股本回報率的公司的集合,或內部人士正在購買的這份股票清單。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

對這篇文章有什麼反饋嗎?擔心內容嗎?保持聯繫直接與我們聯繫。或者,也可以給編輯組發電子郵件,地址是implywallst.com。
這篇由《華爾街日報》撰寫的文章本質上是籠統的。我們僅使用不偏不倚的方法提供基於歷史數據和分析師預測的評論,我們的文章並不打算作為財務建議。它不構成買賣任何股票的建議,也沒有考慮你的目標或你的財務狀況。我們的目標是為您帶來由基本面數據驅動的長期重點分析。請注意,我們的分析可能不會將最新的對價格敏感的公司公告或定性材料考慮在內。簡單地説,華爾街在提到的任何股票中都沒有頭寸。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論